FIELD OF THE INVENTION
[0001] The present invention relates to a novel capsule capable of protecting sensitive
active ingredients (e.g., enzymes, peracid bleaches or bleach catalysts) in liquid
detergent compositions and to liquid detergent compositions comprising the capsules.
BACKGROUND & PRIOR ART
[0002] It is well known in the art that liquid detergents may provide a hostile environment
to sensitive ingredients (e.g., enzymes, peracid bleach, bleach catalysts or perfumes)
used in these detergents. For example, enzymes are subject to attack by, anionic actives,
high pH conditions and/or by other enzymes. Bleaches, in particular peracid bleaches
(such as taught in U.S. Patent 4,909,953 and WO/90,14,336, for example), are known
to be particularly harsh on enzyme components. Encapsulation has been used to protect
these sensitive ingredients in liquid detergent.
[0003] One approach to protecting these sensitive ingredients is to in fact use a polymer
shell surrounding the active component to protect the component. This approach has
been used, for example, in GB 1,390,503 to Unilever; in EP 266,796 to Showa Denko;
and in U.S. Patent No. 4,777,089 (Lion Corp.).
[0004] While such an approach has been effective in protecting active components such as
enzyme or enzymes from being attacked by other enzymes or harsh surfactants, this
type of capsule does not provide an effective barrier to protect the component from
being attacked by bleach. Bleach molecules can penetrate rapidly through the polymer
coating and interact with the sensitive ingredient.
[0005] In copending patent applications U.S. Serial Nos. 07/875,872 and 07/875,914, applicants
teach an encapsulating polymer system comprising a hydrophilic water soluble polymer
or polymers chemically or physically attached to a hydrophobic polymer core particles.
Although these applications teach a kind of "web-like" capsule created by the hydrophilic
molecules entangling and forming an encapsulating net over the core, this "net" is
still too porous to protect the active component, particularly when the liquid composition
is a bleach containing liquid composition
[0006] Another method which has been used to protect active components from the liquid medium
is to place the active in a hydrophobic oil such that the active is protected by the
oil from diffusing into the composition where it is subject to degradative attack.
[0007] Each of U.S. Patent 4,906,396 to Falholt et al.; EP 356,239 to Allied Colloid; and
EP 273,775, for example, provide enzymes protected by hydrophobic oils.
[0008] The use of a hydrophobic oil alone, however, does not provide sufficient protection,
particularly when the composition also contains powerful degradative components such
as the peracid bleaches mentioned above. This may be because the hydrophobic oils
were simply not selected carefully enough to deter migration of the degradative components
toward the active or, conversely, migration of the active toward the degradative component.
[0009] U.S. Patent No. 4,906,396 to Falholt et al. discloses a detergent enzyme dispersed
in a hydrophobic oil. As seen in the examples which follow, the hydrophobic oil is
simply incapable of slowing degradation of the enzyme, for example, when placed in
a bleach containing liquid composition. Again, whether this is because the hydrophobic
oil was not properly selected to sufficiently slow migration of enzyme to bleach or
visa versa is unknown. However, the hydrophobic oil alone simply does not function
effectively such as the capsules of the subject invention.
[0010] In WO 92/20771, Allied Colloids Limited teaches a particulate composition comprising
particles having a substantially anhydrous core comprising a matrix polymer containing
active ingredient, a layer of hydrophobic oil around the core and a polymer shell
around the oil. It is said that the matrix polymer (which contains the active) should
be sufficiently hydrophobic that it will partition into the oil rather than the water.
[0011] The problem addressed by the patent is that, without the hydrophobic matrix polymer,
the active migrates out of the oil too quickly and won't stay in the oil. In other
words, the oil layer is incapable of holding a hydrophilic particle without the hydrophobic
matrix polymer. Although the retention of a hydrophilic active ingredient by the oil
can be enhanced by entrapping the active ingredient with a hydrophobic matrix polymer,
this requires modifying the active ingredient with hydrophobic matrix polymer before
making the capsule. This in turn both is costly and causes the problem of not rapidly
and efficiently releasing the active ingredient in use.
[0012] The subject invention differs from the reference in that the oil layer of the subject
invention is selected such that it can retain a hydrophilic active in the absence
of matrix polymer. Further, as noted above, since the active is not associated with
a hydrophobic matrix polymer, it is more readily and efficiently released in use (e.g.,
when the polymer shell is dissolved).
[0013] Accordingly, there is a need in the art for some kind of capsule composition which
more effectively protects active ingredients, particularly hydrophilic ingredients,
from bleaches or other harsh components found in the detergent composition.
[0014] Further, there is a need to find such a capsule which also readily and efficiently
releases the actives in use, e.g., when the polymeric shell is dissolved or disintegrated.
SUMMARY OF THE INVENTION
[0015] The present invention is directed to a novel capsule system which protects actives
in detergent compositions (i.e., particularly bleach containing compositions) and
which effectively releases the actives in use wherein said capsule system comprises:
(1) an oil dispersion containing the active and in which the oil is selected by meeting
certain defined criteria; and (2) an outer polymer shell surrounding the oil dispersion.
[0016] Accordingly, the present invention provides a capsule composition, preferably for
use in a liquid cleaning composition, comprising:
(a) an active, e.g. subject to degradation by components in a liquid composition;
(b) an oil dispersion containing said active, wherein said oil is defined: (1) by
its ability to retain greater than 80% active in oil after an hour when the dispersion
of active in oil is added to an aqueous solution containing 0.5 wt.% sodium lauryl
sulfate; (2) the ability to suspend said active with less than 10% phase separation
when stored at 37°C for 1 week; and (3) by the ability to release more than 50% active
after 5 minutes of a wash cycle when measured at 40°C; and
(c) a polymer shell surrounding the oil dispersion of (b).
[0017] Preferably, the polymer shell is a water soluble polymer or water dispersible polymers
selected from at least one of the group consisting of polyvinyl alcohol, a polyacrylamide,
polyvinyl pyrrolidone, carrageenan, guar gum, xanthan gum, cellulose and protein.
[0018] The present invention is further directed to detergent compositions comprising such
capsules.
[0019] Accordingly, the present invention provides a detergent composition comprising:
(a) 2 to 60% by weight of a surfactant selected from the group consisting of anionic,
nonionic, cationic, zwitterionic, soap and mixtures thereof; and
(b) a capsule composition for use in said composition comprising:
(i) an active subject to degradation by components in a liquid composition;
(ii) an oil dispersion containing said active, wherein said oil is defined: (1) by
its ability to retain greater than 80% active in oil after an hour when the dispersion
of active in oil is added to an aqueous solution containing 0.5 wt.% sodium lauryl
sulfate; (2) the ability to suspend said active with less than 10% phase separation
when stored at 37°C for 1 week; and (3) by the ability to release more than 50% active
after 5 minutes of a wash cycle when measured at 40°C; and
(iii) a polymer shell surrounding the oil dispersion of (b).
DETAILED DESCRIPTION OF THE INVENTION
[0020] The present invention relates to a novel capsule system which protects actives in
detergent compositions and also rapidly and efficiently releases the encapsulated
active in use. Further, the invention relates to compositions comprising these capsules.
Capsule system
[0021] The capsule system is in effect a combination of (1) an oil dispersion which holds
the actives in place and both keeps the actives from diffusing into solution and also
provides a barrier preventing bleach or other harsh factors/components (anionics or
pH conditions) from coming into contact with the active; and (2) an outer polymer
shell surrounding the oil dispersion to prevent the deformation of the oil dispersion
during and after addition to the liquid detergent.
[0022] The oil in component (1) is selected by meeting a combination of defined criteria
as set forth in greater detail below.
Oil Component
[0023] The first component of the capsule system is the hydrophobic oil component. The oil
components of the invention are defined by meeting each of three defined criteria
set forth below: (1) by their ability to retain active in the dispersion in an aqueous
solution; (2) by their ability to withstand phase separation at ambient or elevated
temperatures over time; and (3) by their ability to rapidly and effectively release
the encapsulated active in use. As noted, the oils must meet all three defined criteria
to be selected as the oil component of the invention.
[0024] According to the first criteria, the oil component is defined by its ability to retain
at least 80% active, preferably 90% after adding the active in oil dispersion to an
aqueous solution containing 0.5 wt.% of surfactant for an hour without mixing. Testing
was done using sodium lauryl sulfate although any suitable surfactant may be used.
[0025] A second criteria by which the oil component is defined is its ability to hold the
active in place and to prevent the active from diffusing or precipitating out of the
oil phase. The stability of active in oil dispersion can be determined by adding the
active in oil dispersion to a 10ml graduated cylinder and measuring the phase separation
of the active from the hydrophobic oil. It should be less than 10%, preferably less
than 5% of phase separation when measured at 37°C for 1 week.
[0026] The last criteria used to define the oil component is its ability to rapidly and
effectively release the active in use. The oil release property can be determined
by a standard Terg-O-Meter washing method. Terg-O-Meter are well known in the art
such as, for example Terg-O-Tometer UR7227. In these devices, generally, 500 mls of
wash liquid are agitated at above 70 rpm for about 20 minutes using desired wash liquid.
[0027] The capsules of the invention were tested using 1000 mls at 100 rpm for 15 minutes
at 40°C.
[0028] The capsule should release more than 50%, preferably more than 70% of the active
after the first five minutes of the wash cycle when measured at 40°C.
[0029] The hydrophobic oil component can be a liquid or a semisolid at room temperature.
Liquid oils alone with a viscosity of less than 10,000 centipoises (cps) such as mineral
oils, silicone oils or vegetable oils are not suitable for this invention and require
modification. These oils do not have the capability to hold and retain hydrophilic
actives and do not provide a sufficient protection to the active in a liquid detergent.
The preferred liquid oil components are oils containing hydrophobic particles with
particle size less than 3µ, preferably less than 1µ, more preferably less than 0.1µ.
Examples of such hydrophobic particles are hydrophobic silica such as Cabot's Cab-O-Sil
TS 720 and Cab-O-Sil TS 530 or Degussa's Aerosil 200; and hydrophobic clay such as
Rheox's Bentone SD-1. These hydrophobic particles can be incorporated into the oil
physically i.e., simply by mixing the oil with the hydrophobic particles or chemically,
i.e., through the chemical interaction of oil with the surface of the particles. The
preferred hydrophobic particles are submicron sized hydrophobically modified fumed
silica such as Cab-O-Sil TS 720. These hydrophobic particles can enhance the suspension
of active in the oil and also increase the capability of oil to retain the active
in an aqueous solution. Typically the amount of hydrophobic particles in the oil is
less than 15%, preferably less than 10%, more preferably less than 5% but more than
0.5% should be used.
[0030] In preferred embodiments of the invention, the oil component is defined by the fact
that it is a semisolid rather than a liquid at room temperature. Specifically, when
the component has a melting temperature of from about 35°C to 70°C, preferably 40°C
to 65°C, the semisolids are found to retain the active more readily. Moreover, such
materials release active under wash condition rapidly enough to give wash performances
comparable to compositions in which enzymes have been newly added. Since these semisolid
oils will also slow migration of active out of the oil phase or slow migration of
bleach and other harsh components toward the active, they are again preferred.
[0031] Examples of such semisolid oils are petrolatums such as Penreco's Penreco Snow, Mineral
Jelly and Tro-Grees; Witco's Multiwax; and fats (e.g., glyceryl ester of C₁₂-C₂₄ fatty
acids) or fat derivatives such as mono-, di- or tri-glycerides and fatty alkyl phosphate
ester. Hydrophobic particles such as hydrophobic fumed silica are also desirably incorporated
into these semisolid oils to further enhance their ability to retain actives, especially
when the capsule of this invention is processed or stored at a temperature close to
or above the melting point of the semisolid oils.
[0032] The oil around the active will generally comprise about 98% to 40%, preferably 90%
to 70% of the active in oil dispersion.
Polymer Coating
[0033] The second component of the capsule system is the polymer coating surrounding the
active in oil dispersion.
[0034] The polymer suitable for this invention must be insoluble in the composition of the
liquid cleaning product and must disintegrate or dissolve during the use of the product
simply by dilution with water, pH change or mechanical forces such as agitation or
abrasion. The preferred polymers are water soluble or water dispersible polymers that
are or can be made insoluble in the liquid detergent composition. Such polymers are
described in EP 1,390,503; U.S. 4,777,089; U.S. 4,898,781; U.S. 4,908,233; U.S. 5,064,650
and U.S. Serial Nos. 07/875,872 and 07/875,194, all of which are incorporated by reference
into the subject application.
[0035] These water soluble polymers display an upper consulate temperature or cloud point.
As is well known in the art (P. Molyneaux, Water Soluble Polymers CRC Press, Boca
Raton, 1984), the solubility or cloud point of such polymers is sensitive to electrolyte
and can be "salted out" by the appropriate type and level of electrolyte. Such polymers
can generally be efficiently salted out by realistic levels of electrolyte (<10%).
Suitable polymers in this class are synthetic nonionic water soluble polymers including:
polyvinyl alcohol; polyvinyl pyrrolidone and its various copolymers with styrene and
vinyl acetate; and polyacrylamide and its various modification such as those discussed
by Molyneaux (see above) and McCormick (in Encyclopedia of Polymer Science Vol 17,
John Wiley, New York). Another class of useful polymers are modified polysaccharides
such as carrageenan, guar gum, pectin, xanthan gum, partially hydrolyzed cellulose
acetate, hydroxy ethyl, hydroxy propyl and hydroxybutyl cellulose, methyl cellulose
and the like. Proteins and modified proteins such as gelatin are still another class
of polymers useful in the present invention especially when selected to have an isoelectric
pH close to that of the liquid composition in which the polymers are to be employed.
[0036] From the discussion above, it is clear that a variety of hydrophilic polymers have
potential utility as the polymer coating for the capsules of this invention. The key
is to select an appropriate hydrophilic polymer that would be essentially insoluble
in the composition (preferably a concentrated liquid system) under the prevailing
electrolyte concentration, yet would dissolve or disintegrate when this composition
is under conditions of use. The tailoring of such polar polymers is well within the
scope of those skilled in the art once the general requirements are known and the
principle set forth.
Capsule
[0037] The capsule of this invention can be produced by a variety of known encapsulation
processes. For example, the capsule can be prepared according to the coacervation
process in which the active in oil dispersion is dispersed to an aqueous solution
of a water soluble or water dispersible polymer. In this procedure, a non-solvent
for the polymer or an electrolyte is added or a pH change or a pressure change is
effected to make the capsule. Examples of this coacervation process are described
in U.S. 4,777,089, U.S. 3,943,063 and U.S. 4,978,483, all three of which are incorporated
herein by reference. Similarly, the capsule can be formed by adding the emulsion of
active in oil in polymer solution to the nonsolvent. In this process, the oil composition
and the emulsification process are critical because the active must stay within the
oil rather than diffuse out during the emulsification of the active in oil dispersion
to a polymer solution. Hydrophobic particles, especially submicron fumed silica, are
especially useful to help the retention of actives in the oil during emulsification.
The oil should contain a sufficient amount of the hydrophobic particles to prevent
the diffusion of the hydrophilic active out of oil. The amount of hydrophobic particles
in the oil is greater than 0.5%, preferably greater than 3% and less than 10%. The
emulsification process should be carried out in a mild condition to prevent overmixing
of the active in oil dispersion with the polymer solution and to ensure the resulting
oil droplet size is larger than the particle size of the active.
[0038] The capsule of the invention also can be prepared by extrusion nozzles as taught
in U.S. 3,310,612, U.S. 3,389,194 or U.S. 2,799,897 and GB 1,390,503. In these processes,
the active in oil dispersion is extruded through the inert orifice of the nozzle.
Simultaneously, the water soluble polymer solution is extruded through the outer orifice
of the nozzle to form a uniform coating on the surface of active in oil dispersion.
The capsule is then formed by breaking the coextrudate at the end of the nozzle orifice
by air, centrifuge force, blade or carry fluid to form droplets which are hardened
in a nonsolvent of the water-soluble polymer to form the capsule.
Active
[0039] The active materials which are desired to be encapsulated by the capsule of this
invention are those materials which will lose their activity in a cleaning product,
especially a bleach-containing liquid cleaning product, if no hydrophobic oil coating
is added according to this invention. The active materials protected by the oil layer
may be a hydrophilic active (e.g., enzyme or bleach catalyst) or a hydrophobic active
(e.g., perfume) and can be solid, liquid or in aqueous solution. If it is a solid
material, the particle size of the active should be less than 200µ preferably less
than 50µ. Of course, since a hydrophobic active is generally readily protected by
an oily layer and is generally not readily degraded by harsh components in composition,
the benefits of the invention are more readily apparent when the active ingredient
is a hydrophilic one. Hydrophilic active materials include enzymes, bleach catalysts
peracid bleaches, bleach activators and optical brighteners.
[0040] One preferred ingredient of the capsules disclosed herein is an enzyme. The enzymes
may be amylases, proteases, lipases, oxidases, cellulases or mixtures thereof. The
amylolytic enzymes for use in the present invention can be those derived from bacteria
or fungi. Preferred amylolytic enzymes are those described in British Patent Specification
No. 1,296,839, cultivated from the strains of
Bacillus licheniformis NCIB 8061, NCIB 8059, ATCC 6334, ATCC 6598, ATCC 11,945, ATCC 8480 and ATCC 9945A.
A particularly preferred enzyme is an amylolytic enzyme produced and distributed under
the trade name, Termamyl, by Novo Industri A/S, Copenhagen, Denmark. These amylolytic
enzymes are generally sold as granules and may have activities from about 2 to 10
Maltose units/milligram. The amylolytic enzyme is normally included in an amount of
from 1% to 40% by weight of the capsule, in particular from 5 to 20% by weight.
[0041] The active may also be a proteolytic enzyme. Examples of suitable proteolytic enzymes
are the subtilisins which are obtained from particular strains of
B. subtilis and B. licheniformis, such as those commercially available under the trade names Maxatase, supplied by
Gist-Brocades NV, Delft, Netherlands, and Alcalase, supplied by Novo Industri A/S,
Copenhagen, Denmark. Particularly preferred are the proteases obtained from a strain
of
Bacillus having a maximal activity throughout the pH range of 8-12, being commercially available
under the trade names of Esperase and Savinase, sold by Novo Industri A/S. These proteolytic
enzymes are generally sold as granules and may have enzyme activities of from about
500 to 50,000 glycine units/milligram. The proteolytic enzyme is normally included
in an amount of from about 1% to about 40% by weight of the capsule, in particular
of from 5% to 20% by weight.
[0042] Lipolytic enzymes may also be included in order to improve removal of fatty soils.
The lipolytic enzymes are preferably included in an amount of from about 1% to about
40%, preferably from 5% to 20% by weight. Cellulase enzymes may be used in an amount
from about 1% to 40% by weight of the capsule.
[0043] The total content of the enzyme in the capsules of the present invention is from
about 1% to about 40%, preferably from about 5% to about 20%.
[0044] It should be understood that the enzyme may also be a genetically engineered variation
of any of the enzymes described have engineered to have a trait (e.g., stability)
superior to its natural counterpart.
[0045] The protected active may also be peroxygen compound activators, peracid bleaches,
bleach catalysts, optical brighteners or perfumes.
[0046] Peroxygen compound activators are organic compounds which react with the peroxygen
salts (e.g. sodium perborate, percarbonate, persilicate) in solution to form an organic
peroxygen acid as the effective bleaching agent. Preferred activators include tetraacetylethylenediamine,
tetraacetyglycoluril, glucosepentaacetate, xylose tetraacetate, sodium benzoyloxybenzene
sulfonate and choline sulfophenyl carbonate. The activators may be released from the
capsule to combine with peroxygen compound in the composition.
[0047] When activator is included, the ratio between the peroxygen in solution and the activator
lies in the range of from 8:1 to 1:3, preferably 4:1 to 1:2, and most preferably is
2:1.
[0048] Although peroxyacids are generally contemplated for use in the composition rather
than the capsule, peroxyacid compounds may be used as the active in the capsule as
well, particularly in compositions where conditions are so harsh as to deactivate
the peroxyacid.
[0049] Generally the peroxyacids are amido or imido peroxyacids and are present in the range
from about 0.5 to about 50%, preferably from about 15 to about 30% by weight of the
capsule. Preferably, the peroxyacid is an amide peracid. More preferably, the amide
is selected from the group of amido peracids consisting of N,N'-Terephthaloyl-di(6-aminopercarboxycaproic
acid) (TPCAP), N,N'-Di(4-percarboxybenzoyl)piperazine (PCBPIP), N,N'-Di(4-Percarboxybenzoyl)ethylenediamine
(PCBED), N,N'-di(4-percarboxybenzoyl)-1,4-butanediamine (PCBBD), N,N'-Di(4-Percarboxyaniline)terephthalate
(DPCAT), N,N'-Di(4-Percarboxybenzoyl)-1,4-diaminocyclohexane (PCBHEX), N,N'-Terephthaloyl-di(4-amino
peroxybutanoic acid) (C₃ TPCAP analogue called TPBUTY) N,N'-Terphthaloyl-di(8-amino
peroxyoctanoic acid) (C₇ TPCAP analogue called TPOCT), N,N'-Di(percarboxyadipoyl)phenylenediamine
(DPAPD) and N,N'-Succinoyl-di(4-percarboxy)aniline (SDPCA). Such compounds are described
in WO 90/14,336.
[0050] Other peroxyacids which may be used include the amidoperoxy acids disclosed in U.S.
Patent Nos. 4,909,953 to Sadowski and U.S. Patent No. 5,055,210 to Getty, both of
which are incorporated by reference into the subject application.
[0051] Also, the active inside the compounds may be a bleach catalyst (i.e. for activating
peracids found in the composition outside the capsule).
[0052] Examples of such catalysts include manganese catalysts of the type described in U.S.
Patent No. 5,153,161 or U.S. patent No. 5,194,416, both of which are incorporated
by reference into the subject application; sulfonomine catalysts and derivatives such
as described in U.S. Patent Nos. 5,041,232 to Batal, U.S. Patent No. 5,045,223 to
Batal and U.S. patent No. 5,047,163 to Batal, all three of which are incorporated
by reference into the subject application.
[0053] More particularly, manganese catalysts include, for example, manganese complexes
of the formula:
[LMn
IV (OR)₃]Y
wherein:
Mn is manganese in the +4 oxidation state;
R is a C₁-C₂₀ radical selected from the group consisting of alkyl, cycloalkyl, aryl,
benzyl and radical combinations thereof; at least two R radicals may also be connected
to one another so as to form a bridging unit between two oxygens that coordinate with
the manganese;
L is a ligand selected from a C₃-C₆₀ radical having at least 3 nitrogen atoms coordinating
with the manganese; and Y is an oxidatively-stable counterior.
[0054] The sulfonomines include compounds having the structure:
R¹R²C=NSO₂R³
wherein:
R¹ may be a substituted or unsubstituted radical selected from the group consisting
of hydrogen, phenyl, aryl, heterocyclic ring, alkyl and cycloalkyl radicals; R² may
be a substituted or unsubstituted radical selected from the group consisting of hydrogen,
phenyl, aryl, heterocyclic ring, alkyl, cycloalkyl, R¹C=NSO₂R³, nitro, halo, cyano,
alkoxy, keto, carboxylic, and carboalkoxy radicals;
R³ may be a substituted or unsubstituted radical selected from the group consisting
of phenyl, aryl, heterocyclic ring, alkyl, cycloalkyl, nitro, halo and cyano radicals;
R¹ with R² and R² with R³ may respectively together form a cycloalkyl, heterocyclic,
and aromatic ring system.
[0055] Sulfonomine derivatives include compounds having the structure:

wherein:
R¹ may be a substituted or unsubstituted radical selected from the group consisting
of hydrogen, phenyl, aryl, heterocyclic ring, alkyl and cycloalkyl radicals;
R² may be a substituted or unsubstituted radical selected from the group consisting
of hydrogen, phenyl, aryl, heterocyclic ring, alkyl, cycloalkyl,

nitro, halo, cyano, alkoxy, keto, carboxylic and carboalkoxy radicals;
R³ may be substituted or unsubstituted radical selected from the group consisting
of phenyl, aryl, heterocyclic ring, alkyl, cycloalkyl, nitro halo, and cyano radicals;
R¹ with R² and R² with R³ may respectively together form a cycloalkyl, heterocyclic,
and aromatic ring system.
[0056] Bleach activators are particularly good candidates for bleach encapsulation both
because they are used in very small amounts and because they are readily deactivated
in solution.
[0057] More specifically, bleach activators are used in an amount from about 1% to 30% by
weight of the capsule composition, preferably, 3% to 15% by weight.
[0058] As mentioned above, the actives may also be optical brighteners or perfumes.
Compositions
[0059] The invention is further directed to the use of the capsules in compositions, particularly
in liquid detergent composition, more particular in aqueous liquid detergent compositions.
Preferably, the compositions are bleach containing aqueous detergent compositions.
In fact, it is in those bleach containing aqueous detergent compositions that the
benefits of the invention became readily apparent since it has previously been extremely
difficult, if not impossible, to formulate capsules for use in bleach containing aqueous
compositions wherein the actives are well protected in the capsule (e.g., greater
than 80% active as defined above), yet readily release upon dilution.
[0060] The aqueous detergent compositions of the invention are typically structured (duotropic)
or unstructured (isotropic) detergent compositions such as described in U.S. Patent
No. 5,089,163 to Aronson et al. or 4,908,150 to Hessel et al. (for isotropic liquids)
or U.S. Patent No. 4,992,194 to Liberati et al. or. U.S. Patent No. 5,147,576 to Montague
et al. (for structured liquids) all of which are incorporated by reference into the
subject application.
[0061] Such compositions will generally comprise water, surfactants, electrolyte (for structuring
and/or building purposes) and other ingredients such as are described below.
[0062] The surfactants may be anionic, nonionic , cationic, zwitterionic, or soap or mixtures
thereof such as those described, for example, in U.S. Patent No. 4,642,198 at columns
3 to 4.
[0063] The total surfactant amount in the liquid composition of the invention may vary from
2 to 60% by weight, preferably from 10 to 50% by weight, depending on the purpose
of use. In the case of suspending liquids comprising an anionic and a nonionic surfactant
the ratio thereof may vary from about 10:1 to 1:10. The term anionic surfactant used
in this context includes the alkali metal soaps of synthetic or natural long-chain
fatty acids having normally from 12 to 20 carbon atoms in the chain.
[0064] The total level of electrolyte(s) present in the composition to provide structuring
may vary from about 1.5 to about 30%, preferably from 2.5 to 25% by weight.
[0065] In addition to the components discussed above, the heavy duty liquid detergent compositions
of the invention may also contain certain optional ingredients in minor amounts. Typical
examples of optional ingredients are suds-controlling agents, fluorescers, perfumes,
coloring agents, abrasives, hydrotropes, sequestering agents, enzymes, and the like
in varying amount.
[0066] Bleaches used in the invention may be any of those described in U.S. patent No. 4,992,194
to Liberati, hereby incorporated by reference. Peroxygen salts include salts such
as sodium perborate, tetrahydrate or monohydrate, percarbonate, persilicate, persulfate,
dipersulfate and the like. Other peroxygen compounds include perphosphates, peroxide
and perpolyphosphates. As indicted above, the peroxygen salts may be activated by
activators which may be encapsulated actives.
[0067] The decoupling polymer is also as disclosed in U.S. Patent No. 4,992,194 Liberati.
The bleaches may also be any of the peracid bleaches described in the "actives" section
(i.e., the mono- or di- percarboxylic amido or imido acids) or the amido peroxy acids
disclosed in U.S. Patent Nos. 4,409,953 and 5,055,210, incorporated by reference.
[0068] In a preferred embodiment of the invention, the composition is a peracid bleach containing
composition and the capsule of the invention (first embodiment) protects the active
(e.g., enzyme or bleach catalyst) from the action of the peracid bleach (and other
harsh components) in the liquid compositions. In this embodiment of the invention,
the peracid bleach may be any of the peracid bleaches described above and are preferably
amides selected from amido peracids such as TPCAP, PCBPIP, PCBED and any of the other
above recited amides peracids when used in the composition, the peracid will comprise
0.1% to 50% by weight, preferably 0.5% to 25% by weight, more preferably 1 to 10%
by weight of the composition.
[0069] The following examples are intended to further illustrate and describe the invention
and are not intended to limit the invention in any way.
EXAMPLES
Preparation of Capsule and Detergent Composition
[0070] The capsule of this invention was prepared as described below using an enzyme slurry
available from NOVO.
[0071] One part of a commercially available silicone enzyme slurry Savinase 16SL/SR (ex.
Novo, 3.5 x 10⁶ GU/g Savinase activity) was added to two parts of neutralized Acrysol
ASE-95 (which is a carboxylic acid containing polyacrylate latex) aqueous solution
(ex. Rohm & Haas, 1.5 wt.%, pH = 7.3-8.0). The mixture was stirred with an overhead
stirrer for 20 minutes to form an enzyme-in-oil-in-water emulsion. The emulsion was
added and hardened in an acid bath (98% water and 2% conc. H₂SO₄) using a Micro Dropper
(Thies Technology) to form a matrix enzyme capsule of about 1,000 micrometers with
2.4 x 10⁶ GU/g enzyme activity. The capsule was hardened in the acid bath for 40 minutes
and stored in glycerol for further use.
[0072] This capsule was incorporated into the liquid detergent formula having the composition
shown in Table 1 below:
TABLE 1
BASE FORMULA OF LIQUID DETERGENT |
Water |
24.8 |
Sorbitol (70%) |
15.8 |
Glycerol |
4.76 |
Sodium Borate 10H20 |
4.76 |
Sodium Citrate 2H20 |
9.52 |
Narlex DC-1 (ex. National Starch & Chem.)* |
3.0 |
50% NaOH |
5.43 |
DB100 (Dow Chem.) (Antifoam) |
0.1 |
Alkyl Benzene Sulfonic Acid |
21.83 |
Neodol 25-9 (Nonionic) |
10.0 |
Total |
100.00 |
* Hydrophobically modified polyacrylic acid aqueous solution having a molecular weight
of about 4,000. Similar polymers are taught in U.S. Patent No. 5,147,576 to Montague
et al. which is hereby incorporated by reference into the subject application. |
[0073] The composition additionally contained sufficient amount of the peracid SBPB to have
1000 ppm active oxygen and was stored at 37°C.
Example 1
[0074] In order to show that the capsule prepared as described above was superior to silicone
enzyme slurry alone (i.e., the non-encapsulated silicone enzyme slurry), applicants
prepared the same silicone enzyme slurry according to the procedure set forth in U.S.
Patent No. 4,906,396 by mixing this same silicone enzyme slurry (Savinase 16SL/SR
(ex. Novo)) in the detergent composition set forth in Table 1 above.
[0075] Applicants additionally compared the residual enzyme activity of the enzyme after
2 and 6 days both when the enzymes were unprotected (i.e., liquid composition alone)
and when the enzyme is used in a PVA/PS (i.e, polyvinylalcohol polystyrene) capsule
as described in U.S. Serial No. 08/037,053 hereby incorporated by reference into the
subject application. The results are set forth in the Table below:
% Residual Activity |
Days |
Liquid* |
PVA/PS |
Slurry** |
Capsule† |
0 |
100 |
100 |
100 |
100 |
2 |
0 |
0 |
44 |
95 |
6 |
- |
- |
< 5 |
68 |
* Liquid - Savinase 16.0L |
** Slurry - Savinase 16 SL/SR |
† Capsule |
[0076] Stabilities studies conducted at 37°C using a duotropic HDL of Table I containing
SBPB
(4,4'-sulfonylbisperoxybenzoic acid) having 1000 ppm active oxygen and enzymes having
18 GU/mg activity
As can be seen from the table above, the stability of the enzyme in the composition
alone or in the composition encapsuled by polymer (PVA/PS) but no oil or slurry, was
almost zero after 2 days. With slurry alone, some improvement was seen. However, the
results using the combination of slurry encapsulation are far superior to the slurry
alone.
[0077] The example clearly shows that the use of both an oil or slurry layer
and encapsulation is superior to either one alone.
Example 2
[0078] In order to determine the stability of enzyme used in compositions comprising bleach
peracids when the enzyme is protected by the capsules of the invention, the stability
of Savinase was tested in composition comprising one of two peracids, N,N'-Di(4-Percarboxybenzoyl)piperazine
(PCBPIP), or N,N'-terephthaloyl-di (6-aminopercarboxycaproic acid) (TPCAP). While
the presence of peracids would normally destroy all enzyme activity almost immediately,
the following results were seen using the capsules of the invention.
Time (days) |
PCBPIP % Residual Enzyme Activity |
0 |
100 |
2 |
99 |
6 |
117 |
13 |
77 |
17 |
57 |
20 |
67 |
31 |
38 |
Time (days) |
TPCAP % Residual Enzyme Activity |
0 |
100 |
4 |
68 |
7 |
58 |
16 |
65 |
23 |
44 |
42 |
32 |
[0079] Capsule composition is that of preparative example (Table 1 above). Stability studies
conducted at 37°C in the same HDL as Table 1 except that it contained one of the two
peracids dosed at 1000 ppm of active oxygen instead of SBPB
The efficiency of the capsules can be clearly seen. Again this example shows efficiency
of encapsulated slurry.
Example 3
[0080] In order to make sure that enzyme is released into wash from the capsules, applicants
tested percent activity released over time and the following results were observed.
Time (minutes) |
% Activity Released |
0 |
14.6 |
5 |
75.9 |
10 |
100.00 |
15 |
96.5 |
Conditions: 40°C+120 ppm Ca⁺² |
[0081] Capsules were placed in the liquid composition described above (Table I)
As can be clearly seen release from capsules is more than 70% at the first 5 minutes
wash and is complete after 10 minutes. The example again shows that the encapsulated
oils release well.
Example 4 and 5 and Comparatives A and B
[0082] In order to show that some hydrophobic oils were superior to others when used in
the capsule, protease was tested in various oils. It should be noted that each of
the capsules were prepared by the matrix method described in the preparatory example.
Results for yield and percent residual activity are set forth below.
[0083] More specifically, slurry compositions were made comprising concentrated savinase
and an oil as follows:
|
Composition |
Savinase Activity (GU/g) of Slurry |
Slurry Composition 1 |
70% Rodisil LV461 (Silicone antifoam 10,000 cps); and 30% Savinase concentrate |
1.6 x 10⁷ |
Slurry Composition 2 (comparative) |
70% Silicone oil 30% Savinase concentrate |
2.4 x 10⁷ |
Slurry Composition 3 (comparative) |
60% Mineral oil 40% Savinase concentrate |
2.7 x 10⁷ |
Slurry Composition 4 |
36% Mineral oil 24% Petrolatum 40% Savinase concentrate |
2.7 x 10⁷ |
[0084] Compositions were then formed from the slurry compositions comprising 66.6% by weight
of the slurry composition and 33.4% by weight ASE 95 solution (1.5%).
[0085] Finally, these compositions were then made into capsules using the matrix encapsulation
method. Capsules formed from slurry compositions 1 and 4 were designated as Examples
4, 5 and capsules formed from slurry compositions 2 & 3 were designated as comparative
examples A&B.
[0086] Applicants then tested (1) the Savinase activity inside the capsule after capsule
was in the composition of Table 1 additionally containing SBPB peracid bleach (4,4-sulfonybisperoxybenzoic
acid) to determine what % of the original activity (as set forth in the table above)
this represented and (2) the % residual activity of enzyme for each capsule when measured
after 3 days at 37°C. Results are set forth below.
|
Savianse Activity in Capsule |
% of Original Activity this Represents |
% Residual Activity After 3 Days at 37°C |
Example 4 |
4.5 x 10⁶ |
28% |
50% |
Comparative A |
2.7 x 10⁵ |
1.2% |
0% |
Comparative B |
1.2 x 10⁵ |
0.4% |
3% |
Example 5 |
1.0 x 10⁶ |
3.7% |
25% |
[0087] As can be clearly seen, Examples 4 and 5, which represent oil or oils meeting all
three criteria of the invention, retained a high % of original activity (28% and 3.7%)
relative to the Comparative examples (1.2% at 0.4%) which oils did not meet all criteria.
In addition, the residual activity after three days was also clearly superior.
[0088] The silicone oil (Comparative A) and mineral oil (Comparative B) showed poor trapping
efficiency and also lost enzyme activity rapidly in the bleach containing liquid.
Addition of petrolatum to mineral oil (Example 5) can enhance the oil trapping efficiency
during capsule preparation and can also dramatically enhance the performance of the
capsule. The same result was observed by using Rhodisil LV461, which is a silicone
oil containing hydrophobically modified silica.
[0089] The examples shows the oil composition is not only important to the trapping efficiency
of enzyme during preparation of the capsule, but is also critical in enhancing enzyme
stability when enzyme is used in a peracid-containing heavy duty liquid detergent.
[0090] While not wishing to be bound by theory it is believed that those oils having the
capability to stop the enzyme from dispersing or diffusing out of the oil and the
capability to minimize the penetration of harsh detergent ingredients into the capsule
during capsule preparation and storage are the ones which show greatest yield and
residual activity over time.
Examples 6-9 and Comparative Examples C, D & E
[0091] The following examples are used to show the preparation of the capsule and the effectiveness
of the capsules in protecting actives/enzymes relative to the closest prior art.
Preparation of Capsule Compositions
Oil Slurries
[0092] Enzyme dispersions were first prepared by dispersing Savinase enzyme particles (protease)
in various oils using Dispermate (UMA-GETZMANN) at 2000 rpm for 10 minutes: The following
seven (7) oil dispersions were prepared:
|
Oil (% by wt.) |
Savinase particle (% by wt.) |
Comparative C |
92% SAG1000 Silicone Antifoam (Union Carbide) |
8% |
6 |
92% Rhodosil LV461 Silicone Antifoam (Rhone-Poulenc) |
8% |
Comparative D |
92% Silicone Oil 10,000 (Union Carbide) |
8% |
Comparative E |
95% Mineral Oil (Fisher) |
8% |
7 |
88.7% Mineral Oil (Fisher)/3.7% Carbosil TS720 |
8% |
8 |
92% Tro-Gress (penreco) |
8% |
9 |
92% Snow White Petrolatum (Penreco) |
8% |
* This was considered to be a comparative because the enzyme particles phase separated
out of the oil during storage. |
Capsules
[0093] Core shell Savinase enzyme capsules (as distinct from the matrix capsule preparation)
were then prepared by encapsulating the enzyme dispersions noted above with a polymer
solution containing polyvinyl alcohol (Airvol 540) and Acrysol ASE-60 (which is an
alkali-soluble emulsion thickener from Rohm & Haas) using a concentric triple nozzle.
[0094] Specifically, the enzyme-in-oil dispersion was fed through the inside orifice, the
polymer aqueous solution was fed through the middle orifice and a compressed air was
passed through the outside orifice to make enzyme capsules of 600 to 800 micrometers.
These capsules were hardened and stored in a salt solution containing 15 weight percent
of sodium sulfate and 2 weight percent of sodium borax with a pH in a range of 6 to
7. The following capsule examples 6-9 and Comparative Examples C-E were thus prepared
from the seven dispersions.
Capsule Examples |
|
Composition of Capsule |
Capsule of Comparative C |
1 part enzyme dispersion 1 (silicone antifoam) and 6.7 parts polymer solution A* |
Capsule 6 |
1 part enzyme dispersion 2 (silicone antifoam) and 6 parts polymer solution A* |
Capsule of Comparative D |
1 part enzyme dispersion 3 (silicone oil 10,000) and 6.7 parts polymer solution A* |
Capsule of Comparative E |
1 part enzyme dispersion 4 (mineral oil) and 6 parts polymer solution B** |
Capsule 7 |
1 part enzyme dispersion 5 (mineral oil and Carbosil) and 6 parts polymer solution
B** |
Capsule 8 |
1 part enzyme dispersion 6 (Tro-Grees 5) and 6 parts polymer solution B** |
Capsule 9 |
1 part enzyme dispersion 7 (Petrolatum) and 6 parts polymer solution B** |
* Polymer Solution A contains 2.7% Airvol 540 PVA (Air product) and 1.3% Acrysol ASE-60
(Rohm & Haas). |
** Polymer Solution B contains 2.3% Airvol 540 and 1.2% Acrysol ASE-60. |
Compositions
[0095] Enzyme capsules 6-9 and capsules comparative C-E were then formulated into a liquid
detergent containing 95.4 wt.% of a stable liquid detergent formula having the following
composition.
BASE FORMULA OF LIQUID DETERGENT |
Water |
24.8 |
Sorbitol (70%) |
15.8 |
Glycerol |
4.76 |
Sodium Borate 10H20 |
4.76 |
Sodium Citrate 2H20 |
9.52 |
Narlex DC-1 (ex. National Starch & Chem.) |
3.0 |
50% NaOH |
5.43 |
DB100 (Dow Chem.) (Antifoam) |
0.1 |
Alkyl Benzene Sulfonic Acid |
21.83 |
Neodol 25-9 (Nonionic) |
10.0 |
Total |
100.00 |
and additionally contain 4.6 wt.% of stable peracid N,N'-Terephthaloyl di(6-aminopercarboxycaproic
acid) (TPCAP) which was prepared as described in WO Patent 9,014,336.
[0096] The enzyme capsules were incorporated into the above-identified formulation to give
16,000 GU enzyme activity per gram of the formulated liquid detergent. These formulated
samples were stored at 37°C and the residual Savinase activity of these stored samples
was determined and given in the left column of the Table shown below:
Table
Residual Enzyme Activity of Examples |
|
% Residual Enzyme Activity (when encapsulated) |
% Residual Enzyme Activity (when not encapsulated) |
Comparative C |
45% after 6 days 28% after 20 days |
0% after 3 days |
Example 6 |
22.4% after 14 days |
0% after 3 days |
Comparative D |
35% after 6 days 18% days after 20 days |
0% after 3 days |
Comparative E |
38.3% after 14 days |
0% after 3 days |
Example 7 |
61.7% after 14 days |
0% after 3 days |
Example 8 |
76.8% after 14 days |
0% after 3 days |
Example 9 |
76.6% after 14 days |
7% after 6 days |
[0097] In order to show that the capsules of the invention function by retaining enzyme
activity while the enzyme slurry alone (i.e., nonencapsulated) cannot and does not
retain the same enzyme levels, applicants prepared the same Examples 6-9 and comparative
examples C-E, but did
not encapsulate (i.e., right hand column of Table). The slurry only examples correspond
to the system used in U.S. Patent No. 4,906,396 to Falholz.
[0098] The slurry-only examples were prepared by stirring the prepared enzyme-in-oil dispersion
into the same liquid detergent as used in the capsule examples which contained 4.6%
TPCAP peracid and was stored at 37°C. As noted, the residual Savinase enzyme activity
of these slurry-only examples was shown in the right column of the Table.
[0099] The enzyme stability data summarized in the Table clearly shows that the protected
enzyme system as claimed by U.S. 4,906,396 did not provide a protection to the enzyme
in the bleach-containing liquid detergent. Almost 0% of enzyme activity remained for
all of the slurry-only examples after being stored at 37°C for less than 1 week. Depending
on the oil used in the capsule composition of this invention, 22 to 78% of enzyme
activity still remained after being stored in this bleach-containing liquid for 2
weeks.
Example 10 - Performance
[0100] The performance of 3 Savinase enzyme capsules (Examples 6, 8 and 9) of this invention
was compared with a liquid Savinase in the wash for stain removal. A test cloth (AS10
Cloth, ex. Center for Test Material) stained with casein, pigments and oils was used.
The performance of these Savinase capsules containing liquid detergent and the control
sample containing the liquid Savinase was summarized in Table 2 below. Delta Delta
R values, which indicates the whiteness of the washed cloth, show the capsule of this
invention released the encapsulated enzyme and performed the same as the free Savinase.
Table 2 is set forth below:
TABLE 2
ENZYME RELEASE IN WASH |
Enzyme Sample |
Delta Delta R |
Control (Savinase Liquid) |
11.0 |
Capsule of Example 6 |
7.9 |
Capsule of Example 8 |
9.3 |
Capsule of Example 9 |
10.5 |
Example 11
[0101] Another example using encapsulated lipase is described below:
A Lipolase enzyme particle was prepared by spray drying a mixture of 30 wt.% Lipolase
100L (Novo) and 70 wt.% of Airvol 1603/polystyrene latex to give an enzyme particle
with 210 x 10³ LU/g Lipolase activity. A Lipolase-in-oil dispersion was prepared by
dispersing 25 wt.% of this Lipolase particle to 75 wt.% of Rhodosil LV461 Silicone
antifoam (ex. Rhone-Poulenc). One part of the Lipolase-in-oil dispersion was mixed
with 3 parts of Acrysol ASE-95 solution (1.8 wt.%, pH 7.5-8.0) with an overhead stirrer
to make an enzyme-in-oil-in-Water emulsion. A matrix enzyme capsule was prepared by
adding the Lipolase-in-oil-in-water emulsion dropwise to an acid bath containing 98%
water and 2% concentrate H₂SO₄. The capsule has a particle size about 1,000 micrometers
and 19 x 10³ LU/g Lipolase activity. A liquid detergent containing 88 wt.% of the
base liquid detergent of Examples 6-9, 10 wt.% benzoyl peroxide and 2% of Lipolase
capsule was formulated and stored at 37°C. A comparative example containing the nonencapsulated
Lipolase 100L was also formulated with the same liquid detergent containing 10 wt.%
benzoyl peroxide and stored at 37°C for 1 week is: 0% for the comparative example
and 58% for the Lipolase capsule of this invention.
Examples 12-14
[0102] The following examples were used to show the preparation and the effectiveness of
the capsules in protecting PAP in a heavy duty liquid.
Preparation of Capsule Components:
PAP-in-Oil Dispersions:
[0103] PAP (phthalamidoperoxycaproic acid) dispersions were prepared by mixing PAP crystal
in the various oils meeting the criteria set forth in the invention using Dispermat
(F1, VMA-Getzmann) at 2000 rpm for 10 minutes. Three dispersions were prepared, as
shown in the Table below:
TABLE
PAP-in-Oil Dispersions |
No |
Oil |
PAP Crystal (wt%) |
|
Type |
wt.% |
|
1 |
Silicone Antifoam (LV461, Rhodosil) |
80 |
20 |
2 |
Tro-Grees (Spray S, Penreco) |
80 |
20 |
3 |
Petrolatum (Snow White, Penreco) |
80 |
20 |
[0104] Each of these oils has the characteristics defining the oils of the invention (i.e.,
retains greater than 80% crystals, preferably greater than 90% crystal after capsule
preparation, suspends active with less than 10% phase separation under defined conditions
and releases per defined conditions).
Capsules:
[0105] Core-shell PAP capsules were then prepared by encapsulating the PAP dispersions noted
above with a polymer solution containing 3.3 wt.% of polyvinyl alcohol (Airvol 540,
Air Products) and 1.7 wt.% of alkaline soluble polymer (ASE-60, Rhom & Haas) using
a concentric triple nozzle.
[0106] Specifically, the PAP-in-oil dispersion, polymer solution, and compressed air were
simultaneously fed to the nozzle tip through the central, middle, and outer orifices,
respectively. Three PAP capsules of 600-800 µm were prepared from the three dispersions,
as shown in the Table below:
Table 2
PAP Core-Shell Capsules |
Example |
Capsule Composition |
Capsule 12 |
1 part of PAP dispersion 1 (Silicone Antifoam) and 5 parts of polymer solution |
Capsule 13 parts of polymer |
1 part of PAP dispersion 2 (Tro-Grees) and 5 solution |
Capsule 14 parts of polymer |
1 part of PAP dispersion 3 (Petrolatum) and 5 solution |
Composition:
[0107] PAP capsules 1-3 were then formulated into a liquid detergent having the following
composition:
Table 3
Basic Formula of Liquid Detergent |
Ingredients |
Wt.% |
Sorbitol (70%) |
15.8 |
Glycerol |
4.8 |
Sodium Borate 10 H₂O |
4.8 |
Sodium Citrate 2 H₂O |
9.5 |
Narlex DC-1 (33%) |
2.9 |
Sodium Hydroxide (50%) |
5.5 |
DB 100 (Silicone antifoam) |
0.1 |
BDA (Alkyl benzene sulphonic acid) |
21.8 |
Neodol 25-9 (Nonionic surfactant having average alkoxylation of about 9) |
10.0 |
Water |
24.9 |
[0108] PAP capsule was incorporated into the formulation to give 4000 ppm of active oxygen
per gram of the formulated liquid detergent. These formulated samples were stored
at 37°C and the residual PAP activity of these stored samples was determined and given
in the Table below.
Table 4
Residual PAP Activity of Examples 12-14 |
Example No. |
Storage Time (days) |
Residual Activity (%) |
PAP Crystal |
2 |
50 |
3 |
25 |
Capsule 12 |
4 |
50 |
6 |
25 |
Capsule 13 |
8 |
50 |
15 |
30 |
Capsule 14 |
15 |
75 |
30 |
52 |
[0109] The stability results show the stability of PAP in a liquid detergent can be dramatically
enhanced by protecting PAP in the capsule of this invention.
Example 15
[0110] The following examples are used to show the preparation and the effectiveness of
the capsules in protecting manganese bleach catalyst [MnMeTACN,di(N,N',N''-trimethyl-1,4,7,-triazacyclononane)-tri(Mu-oxo)-dimanganese
(IV)di(hexafluorophosphate-monohydrate)] in a heavy duty liquid detergent.
Preparation of Capsule Components:
Catalyst-in-Oil Dispersions:
[0111] Catalyst dispersions were prepared by mixing the manganese bleach catalyst in various
oils using Dispermat (Fl, VMA-Getzmann) at 2000 rpm for 10 minutes. The dispersion
contained 81% of Tro-Grees, 9% of Petrolatum, and 10% of manganese bleach catalyst.
Capsules:
[0112] The core-shell bleach catalyst capsule was then prepared by encapsulating the bleach
catalyst dispersions same as Examples 12-14 with a polymer solution containing 3.3
wt.% of polyvinyl alcohol (Airvol 540, Air Products) and 1.7 wt.% of alkaline soluble
polymer (ASE-60, Rhom & Haas) using a concentric triple nozzle.
[0113] Specifically, the catalyst-in-oil dispersion polymer solution and compressed air
were simultaneously fed to the nozzle tip through the central, middle and outer orifices,
respectively.
Compositions of Bleach Catalyst Capsules |
Example No. |
Capsule Composition |
15 |
1 part of magnesium bleach catalyst dispersion 1 (mixture of Petrolatum and Tro-Grees)
and 8 parts of polymer solution |
[0114] The capsules were then formulated into a liquid detergent having the following composition:
Table 3
Basic Formula of Liquid Detergent |
Ingredients |
Wt.% |
Sodium Metaborate |
1.50 |
Sodium Perborate |
10.00 |
Sodium Citrate |
10.00 |
Narlex DC-1 (33%) |
4.50 |
BDA (97%) |
20.10 |
Neodol 25-9 |
8.60 |
Antifoam |
0.25 |
Water |
35.0 |
Sodium Hydroxide (50%) adjust pH to 10 |
[0115] The capsule was incorporated into the formulation to give 0.2% of active bleach catalyst
in the formulated liquid detergent. The formulated samples were stored at 37°C and
22°C the residual catalyst activity of these stored samples was determined and given
in the Table below.
Example No. |
Storage Temperature (°C) |
Storage Time (days) |
Residual Activity (%) |
Bleach |
37 |
1 |
0% |
Catalyst (compartive) |
22 |
1 |
0% |
Bleach |
37 |
5 |
95% |
Catalyst |
22 |
5 |
98% |
Capsule (Example 15) |
37 |
45 |
52% |
22 |
45 |
72% |